Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B2 | P19099 | 7/20 | 0.38 |
| ▸ | CYP11B1 | P15538 | 5/20 | 0.38 |
| ▸ | SLC22A12 | Q96S37 | 4/20 | 0.38 |
| ▸ | CHUK | O15111 | 1/20 | 0.37 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.36 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.36 |
| ▸ | GSK3A | P49840 | 1/20 | 0.35 |
| ▸ | GSK3B | P49841 | 1/20 | 0.35 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.35 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.35 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.35 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.34 |
| ▸ | FLT3 | P36888 | 2/20 | 0.34 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21758474 | 0.96 | CHUK (0.38) | CYP11B2CYP11B1SLC22A12CHUKPTGER4 | |
| SCHEMBL21396786 | 0.93 | CYP11B2 (0.36) | CYP11B2CYP11B1SLC22A12CHUKPTGER4 | |
| SCHEMBL21758710 | 0.92 | CYP19A1 (0.34) | CYP11B2CYP11B1SLC22A12CHUKPTGER4 | |
| SCHEMBL21758709 | 0.92 | CYP19A1 (0.34) | CYP11B2CYP11B1SLC22A12CHUKPTGER4 | |
| SCHEMBL21758159 | 0.91 | CYP11B2 (0.37) | CYP11B2CYP11B1SLC22A12CHUKPTGER4 | |
| SCHEMBL21758488 | 0.91 | CYP11B2 (0.39) | CYP11B2CYP11B1SLC22A12PTGER4CYP17A1 | |
| SCHEMBL21396773 | 0.91 | CHUK (0.38) | CYP11B2CYP11B1SLC22A12CHUKPTGER4 | |
| SCHEMBL21396781 | 0.91 | CYP11B2 (0.39) | CYP11B2CYP11B1SLC22A12CHUKPTGER4 | |
| SCHEMBL21758484 | 0.90 | CHUK (0.42) | CYP11B2CYP11B1SLC22A12CHUKGSK3A | |
| SCHEMBL21397128 | 0.89 | CYP11B2 (0.39) | CYP11B2CYP11B1SLC22A12CHUKCYP17A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3543230-B1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | SAMSUNG DISPLAY CO LTD (KR) | 2021-05-05 | — | — | EP | disclosed |
| US-20190296247-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-09-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190296247-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | SLC25A21, SLCO4C1, SLC18A1 | CYP11B2 1859/4885CYP11B1 1877/4885SLC22A12 224/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.